Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Insight Molecular Diagnostics Inc. (IMDX) Stock · SELL · CRISIS | LOPJLB

Insight Molecular Diagnostics Inc. (IMDX)

Healthcare · Medical - Diagnostics & Research · NASDAQ · US

$3.37+2.74%Close

SELLCRISIS · day 10

IMDX▼ SELL

$3.37+2.74%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $109M
Beta: 1.80
P/E (TTM): -2.22

Short % float: 9.65%
Days to cover: 2.9
SI change: -2.0%

1W: -2.03%
1M: -15.33%

vs SPY 1W: -3.20%
vs SPY 1M: -18.32%

Industry peers

FMP comparable companies · ranked by market cap

OABIBUYOmniAb, Inc.$676MBEARQ -11$4.66+2.79%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories.…

Employees: 57
Headquarters: US
Founded: 2015
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares out: 32.3M
Float: 31.2%

imdxinc.com ↗

Key executives

Joshua Riggs — President, Chief Executive Officer & Director

Ekkehard Schutz — Chief Science Officer

Andrea Susan James — Chief Financial Officer

SEC filings

EDGAR · CIK 16423800 · IMDX

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish763.6%

Neutral436.4%

Bearish00.0%

L $8.00Avg $9.75H $12.00

Target$9.75+189.32%

Last$3.37

Company news

globenewswire.com · 38d ago

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

seekingalpha.com · 54d ago

Insight Molecular Diagnostics Inc. (IMDX) Discusses Advances in Heart Transplant Rejection Testing and Evolution of Diagnostic Methods Transcript

globenewswire.com · 60d ago

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

seekingalpha.com · 60d ago

Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript

globenewswire.com · 67d ago

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

globenewswire.com · 79d ago

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

globenewswire.com · 86d ago

Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio

Market news & ticker search · RSS for IMDX

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE